Gilead Sciences

Gilead Sciences stock: Is gild outperforming the healthcare sector? Barchart04:13
Gilead and Tubulis sign ADC development deal for cancer treatment Pharmaceutical Business Review05:36
Gilead adds investigational HIV vaccine to its portfolio from Spanish biotech Pharmaceutical Technology07:49
Gilead gets $31.8M In Calif. Case over counterfeit HIV drugs Law36019:23
Gilead’s twice-yearly lenacapavir shows promise in HIV prevention trial Clinical Trials Arena07:55
Gilead’s Trodelvy awaits re-deliberation for reimbursement in Korea following patient petitions, price cut proposal Korea Biomedical Review00:54

Latest News

In the last 7 days
Executives On The Move: 17 New CEOs, Nine CFOs And Four CMOs Among This Week’s Changes Scrip Pharma Intelligence09:47 5-Dec-24
Gilead Sciences Stock: Is GILD Outperforming the Healthcare Sector? Barchart04:13 5-Dec-24
Precision Medicine Market to grow by USD 66.2 Billion (2024-2028), rising chronic disease… PR Newswire (Press Release)15:35 4-Dec-24
Gilead and Tubulis sign ADC development deal for cancer treatment Pharmaceutical Business Review05:36 4-Dec-24
Gilead Expands ADC Presence With Tubulis Licensing Deal Scrip Pharma Intelligence16:35 3-Dec-24
Gilead looks beyond Trodelvy with Tubulis alliance pharmaphorum08:12 3-Dec-24
Gilead and Tubulis Enter Into Exclusive Option and License Agreement to Develop ADC Candidate… Business Wire (Press Release)07:01 3-Dec-24
Gilead Sciences Inc a Top Socially Responsible Dividend Stock With 3.3% Yield (GILD) Nasdaq08:02 2-Dec-24
Jason Veasey, Joe Barros, Nikka Graff Lanzarone, Mark MacKillop, More Will Honor World AIDS Day Through Story and Song Playbill09:09 1-Dec-24
In the last month
Gilead’s twice-yearly lenacapavir shows promise in HIV prevention trial Clinical Trials Arena07:55 28-Nov-24
Gilead Announces New England Journal of Medicine Publication of PURPOSE 2 Results Business Wire (Press Release)17:09 27-Nov-24
Gilead Gets $31.8M In Calif. Case Over Counterfeit HIV Drugs Law36019:23 26-Nov-24
Antibody Drug Conjugate Market Industry Trends and Forecasts to 2035, Featuring Profiles of Key Players ADC… GlobeNewswire (Press Release)11:55 26-Nov-24
Gilead adds investigational HIV vaccine to its portfolio from Spanish biotech Pharmaceutical Technology07:49 26-Nov-24
Gilead’s Trodelvy awaits re-deliberation for reimbursement in Korea following patient petitions, price cut proposal Korea Biomedical Review00:54 25-Nov-24
The Children's Inn at NIH Announces $1 Million Grant From Gilead Sciences, Inc. Business Wire (Press Release)16:30 22-Nov-24
How Gilead Is Driving Global Health Equity And Innovation Forbes10:55 20-Nov-24
WATCH: Dominique Jackson Talks Mutual Aid, Safety, and More with Transgender Community Leaders for… GLAAD14:47 19-Nov-24
TOUCH, The Black Breast Cancer Alliance and Partners Launch the Black TNBC Sanctuary Resource… Business Wire (Press Release)11:58 19-Nov-24
New Data Provide Clearer Picture on Adherence to Lenacapavir American Journal of Managed Care13:04 18-Nov-24
Gilead’s Livdelzi shows promise in PBC clinical trial Clinical Trials Arena09:40 18-Nov-24
IDEAYA Biosciences Appoints Stu Dorman as Chief Commercial Officer PR Newswire (Press Release)06:02 18-Nov-24
Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and… GlobeNewswire (Press Release)10:37 17-Nov-24
Gilead’s Irish business sees profit slump on falling sales of Covid drug The Irish Times01:07 16-Nov-24
Regenerative Medicine Market to grow by USD 70.11 Billion (2024-2028), rising prevalence of… PR Newswire (Press Release)17:07 15-Nov-24
Gilead Unveils Long-Term Data From Seladelpar In Patients With Rare Liver Disease Benzinga14:19 15-Nov-24
Gilead’s Livdelzi (Seladelpar) Demonstrated a Sustained Efficacy and Long-Term Safety Profile… Business Wire (Press Release)11:02 15-Nov-24
As an HIV+ activist, I know drug companies aren't doing enough to end AIDS Yahoo! UK & Ireland09:23 15-Nov-24
Trump's Victory Spurs $50B Corporate Bond Surge As Tax Cut Optimism Drives Borrowing Costs To 25-Year Low Benzinga06:08 15-Nov-24
COVID drugmaker to close Seattle office, laying off 72 workers The Seattle Times18:03 14-Nov-24
See Which Of The Latest 13F Filers Holds Gilead Sciences Nasdaq10:33 14-Nov-24
Gilead Prices $3.5 Billion of Senior Unsecured Notes Business Wire (Press Release)20:31 13-Nov-24
Gilead data lends insight into transforming HIV prevention landscape European Pharmaceutical Review17:47 13-Nov-24
Priced - Gilead Sciences US$3.5bn 4-part senior notes; 5yr/10yr/30yr/40yr International Financing Review15:10 13-Nov-24
Cell and Gene Therapy Market to Grow by USD 6.56 Billion (2024-2028), Driven by Rising… PR Newswire (Press Release)14:17 13-Nov-24
Launch - Gilead Sciences US$3.5bn 4-part senior notes; 5yr/10yr/30yr/40yr International Financing Review13:28 13-Nov-24
Guidance - Gilead Sciences US$ benchmark 4-part senior notes; 5yr/10yr/30yr/40yr International Financing Review12:37 13-Nov-24
Announced - Gilead Sciences US$ benchmark 4-part senior notes; 5yr/10yr/30yr/40yr International Financing Review09:22 13-Nov-24
Gilead Presents Full PURPOSE 2 Data Results for Twice-Yearly Lenacapavir for HIV Prevention at… Business Wire (Press Release)06:48 13-Nov-24
Gilead Seals VLs For Lenacapavir Amid Concerns Around Price, API Supplies Scrip Pharma Intelligence06:01 12-Nov-24
Scientific Leadership Spotlighted as Gilead Presents Research Data Across Its Broad and… Business Wire (Press Release)05:32 12-Nov-24
Gilead Sciences: Approaching Overvalued Seeking Alpha15:53 11-Nov-24
3 Spectacular High-Yield Dividend Stocks to Buy in November The Motley Fool09:37 10-Nov-24
Gilead Sciences to Present at Upcoming Investor Engagements Business Wire (Press Release)16:06 8-Nov-24
Gilead Sciences Stock: Analyst Estimates & Ratings Barchart08:23 8-Nov-24
Gilead Beats Whistleblower Claim, Must Face Illegal Firing Charge Bloomberg Law20:29 7-Nov-24
Case: Individual Employment Rights/Wrongful Discharge (W. D. Pa.) Bloomberg Law17:31 7-Nov-24
Pulmonary Arterial Hypertension Drugs Market to Grow by USD 2.26 Billion from 2024-2028, as… PR Newswire (Press Release)15:06 7-Nov-24
Gene Therapy Market to Grow by USD 6.74 Billion from 2024-2028, as Rise in Special Drug… PR Newswire (Press Release)13:55 7-Nov-24
HIV Drugmaker Gilead Reports Strongest Quarterly Performance Of 2024, Analysts Boost Price Target On Raised Outlook Benzinga13:52 7-Nov-24
Pulmonary Embolism Therapeutics Market to Grow by USD 14.02 Billion from 2024-2028, Driven by… PR Newswire (Press Release)13:34 7-Nov-24
Gilead increases 2024 outlook, expects new drug filing by end of year Yahoo! UK & Ireland13:00 7-Nov-24
Gilead Sciences Tops Estimates in Q3 The Motley Fool11:54 7-Nov-24
Late-Breaking Clinical Data and Real-World Evidence Presented at HIV Glasgow as Gilead Extends… Business Wire (Press Release)08:39 7-Nov-24
Gilead Sciences Shows Strong Q3 Results Amid Strategic Initiatives TipRanks23:15 6-Nov-24
Business Groups Urge Calif. Justices To Nix HIV Drug Ruling Law36018:07 6-Nov-24

      
            
      
    view more headlines
   
      
      
      
5 Dec 09:47
   

Gilead Sciences

Latest News

Biotech Top Stories

Business Top Stories